American Society of Clinical Oncology

SHERPA: White

People

  1. Morris
    Morris
  2. Schoder
    Schoder
  3. Reuter
    Reuter
  4. Baxi
    Baxi
  5. Boucai
    Boucai
  6. Carrasquillo
    Carrasquillo
  7. Cheng
    Cheng
  8. Chen
    Chen
  9. Cross
    Cross
  10. Danila
    Danila

Groups

  1. Molecular Imaging and Therapy Service (9)
  2. Department of Medicine (8)
  3. Radiology, Department of (8)
  4. GSK Faculty (5)
  5. Solid Tumor Oncology Division (5)
  6. Genitourinary Oncology Service (4)
  7. Hematologic Malignancies, Division of (4)
  8. Molecular Pharmacology and Chemistry Program Faculty (3)
  9. Sloan Kettering Institute Faculty (3)
  10. Center for Hematologic Malignancies (2)
Search Within
  1. "2016"
  2. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Molecular Imaging and Therapy Service (9)
  2. Department of Medicine (8)
  3. Radiology, Department of (8)
  4. GSK Faculty (5)
  5. Solid Tumor Oncology Division (5)
  6. Genitourinary Oncology Service (4)

More Groups

People
  1. Craig Moskowitz (3)
  2. Heiko Schoder (3)
  3. Michael Morris (3)
  4. Steven Larson (3)
  5. Victor Reuter (2)
  6. Abraham Hakimi (1)

More People

Years
  1. 2016 (9)
Publications
  1. Journal of Clinical Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer
    Meeting Abstract

    Parkinson, C. A.; Gale, D.; Piskorz, A.; Hodgkin, C.; Biggs, H.; Addley, H.; Moyle, P.; Freeman, S.; Sala, E.; Hosking, K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic and metabolic characterization of succinate dehydrogenase B deficient renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Wei, E.; Lee, W.; Chen, Y.; Mano, R.; Hakimi, A. A.; Dong, Y.; Redzematovic, A.; Cross, J. R.; Tickoo, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy
    Meeting Abstract

    Gavane, S. C.; Ito, K.; Moskowitz, C. H.; Moskowitz, A. J.; Schoder, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume in lymphoma: Hype or hope?
    Journal Article

    Schòˆder, H.; Moskowitz, C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • [(18)F] NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer
    Meeting Abstract

    Harmon, S.; Perk, T.; Eickhoff, J. C.; Staab, M. J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Morris, M. J.; Larson, S. M.; Ohlsson, M.; Joseffson, A.; Helgstrand, J. T.; Edenbrandt, L.; Oturai, P. S.; Roeder, M. A.; Bjartell, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816
    Journal Article

    Press, O. W.; Li, H.; Schòˆder, H.; Straus, D. J.; Moskowitz, C. H.; LeBlanc, M.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; Mittra, E. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save